Posted 04 August, 2023
MIRA PHARMACEUTICALS, INC. IPO completed
IPO completed detected for ticker Nasdaq:MIRA in a 424B1 filed on 04 August, 2023.
This is the initial public offering of 1,275,000 shares of our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of MIRA PHARMACEUTICALS, INC.
Health Care/Life Sciences • Pharmaceuticals
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.Market Cap
$14.6M
View Company Details
$14.6M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.